EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranasal Mitochondrial Transplantation Restores Mitochondrial Function and Modulates Glial–Neuronal Interactions in a Genetic Parkinson’s Disease Model of UQCRC1 Mutation

Jui-Chih Chang iD, Chin-Hsien Lin, Cheng-Yi Yeh, Mei-Fang Cheng iD, Yi-Chieh Chen iD, Chi-Han Wu, Hui-Ju Chang, Chin-San Liu iD

Cells · 25.07.2025 · 14 (15) · 1148

DOI: 10.3390/cells14151148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 25.07.2025. Verfasst von Jui-Chih Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Regenerative Medicine and Tissue Repair, Institute of ATP, Changhua Christian Hospital, Changhua 50094, Taiwan. Hauptthemen laut MEDLINE: Mitochondria, Parkinson Disease, Neuroglia, Neurons. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhua Christian Hospital, Taiwan, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intranasal delivery of exogenous mitochondria is a potential therapy for Parkinson’s disease (PD). The regulatory mechanisms and effectiveness in genetic models remains uncertain, as well as the impact of modulating the mitochondrial permeability transition pore (mPTP) in grafts. Utilizing UQCRC1 (p.Tyr314Ser) knock-in mice, and a cellular model, this study validated the transplantation of mitochondria with or without cyclosporin A (CsA) preloading as a method to treat mitochondrial dysfunction and improve disease progression through intranasal delivery. Liver-derived mitochondria were labeled with bromodeoxyuridine (BrdU), incubated with CsA to inhibit mPTP opening, and were administered weekly via the nasal route to 6-month-old mice for six months. Both treatment groups showed significant locomotor improvements in open-field tests. PET imaging showed increased striatal tracer uptake, indicating enhanced dopamine synthesis capacity. The immunohistochemical analysis revealed increased neuron survival in the dentate gyrus, a higher number of tyrosine hydroxylase (TH)-positive neurons in the substantia nigra (SN) and striatum (ST), and a thicker granule cell layer. In SN neurons, the function of mitochondrial complex III was reinstated. Additionally, the CsA-accumulated mitochondria reduced more proinflammatory cytokine levels, yet their therapeutic effectiveness was similar to that of unmodified mitochondria. External mitochondria were detected in multiple brain areas through BrdU tracking, showing a 3.6-fold increase in the ST compared to the SN. In the ST, about 47% of TH-positive neurons incorporated exogenous mitochondria compared to 8% in the SN. Notably, GFAP-labeled striatal astrocytes (ASTs) also displayed external mitochondria, while MBP-labeled striatal oligodendrocytes (OLs) did not. On the other hand, fewer ASTs and increased OLs were noted, along with lower S100β levels, indicating reduced reactive gliosis and a more supportive environment for OLs. Intranasally, mitochondrial transplantation showed neuroprotective effects in genetic PD, validating a noninvasive therapeutic approach. This supports mitochondrial recovery and is linked to anti-inflammatory responses and glial modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaParkinson DiseaseNeurogliaNeuronsMutationElectron Transport Complex IIIAnimalsDisease Models, AnimalAdministration, IntranasalMiceMice, Inbred C57BLMaleCyclosporine

Stichwörter der Autor:innen

Parkinson’s diseaseUQCRC1 mutation (p.Tyr314Ser) knock-in micecyclosporine Aglial modulationinflammatory cytokinesintranasal deliverymitochondrial functionmitochondrial transplantationneuroprotectionstriatal astrocytesstriatal oligodendrocytes

Substanzen

Electron Transport Complex IIICyclosporine

Autor:innen und Institutionen

  • Center of Regenerative Medicine and Tissue Repair, Institute of ATP, Changhua Christian Hospital, Changhua 50094, Taiwan.
  • Department of Neurology, National Taiwan University Hospital, Taipei 10051, Taiwan.
  • Department of Nuclear Medicine, National Taiwan University Hospital, Taipei 10051, Taiwan.
  • Department of Nuclear Medicine, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
  • Molecular Imaging Center, National Taiwan University, Taipei 106319, Taiwan.
  • Vascular and Genomic Center, Institute of ATP, Changhua Christian Hospital, Changhua 50094, Taiwan.

ORCID-Profile: Jui-Chih Chang, Mei-Fang Cheng, Yi-Chieh Chen, Chin-San Liu

Förderung

  • Changhua Christian Hospital, Taiwan
  • Ministry of Science and Technology, Taiwan

Zitieren

APA

Chang, J. C., Lin, C. H., Yeh, C. Y., Cheng, M. F., Chen, Y. C., Wu, C. H., Chang, H. J., & Liu, C. S. (2025). Intranasal Mitochondrial Transplantation Restores Mitochondrial Function and Modulates Glial–Neuronal Interactions in a Genetic Parkinson’s Disease Model of UQCRC1 Mutation. Cells, 14(15), 1148. https://doi.org/10.3390/cells14151148

Vancouver

Chang JC, Lin CH, Yeh CY, Cheng MF, Chen YC, Wu CH, et al. Intranasal Mitochondrial Transplantation Restores Mitochondrial Function and Modulates Glial–Neuronal Interactions in a Genetic Parkinson’s Disease Model of UQCRC1 Mutation. Cells. 2025;14(15):1148. doi:10.3390/cells14151148

BibTeX
@article{Chang2025,
  author = {Chang, Jui-Chih and Lin, Chin-Hsien and Yeh, Cheng-Yi and Cheng, Mei-Fang and Chen, Yi-Chieh and Wu, Chi-Han and Chang, Hui-Ju and Liu, Chin-San},
  title = {Intranasal Mitochondrial Transplantation Restores Mitochondrial Function and Modulates Glial–Neuronal Interactions in a Genetic Parkinson’s Disease Model of UQCRC1 Mutation},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {15},
  pages = {1148},
  doi = {10.3390/cells14151148}
}
Kostenlos starten →